AptaMatrix, Inc. Receives $2M NIH SBIR Phase II Award
CNYBAC Client AptaMatrix, Inc. Receives $2M NIH Small Business Innovation Research Phase II AwardAptaMatrix, Inc., a Syracuse-based biotech company focused on developing aptamer-based technologies for diagnostic applications, announces that it has been awarded a $2M Phase II Small Business Innovati...
AptaMatrix, Inc. Receives $2M NIH SBIR Phase II Award